Olivier Gires
Munich, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 70 publications
Targeting EpCAM expression via near-infrared fluorescent antibodies enables microscopic delineation of primary and recurrent HNSCC.
Journal: BMC cancer
Published: January 10, 2026
Personalized ctDNA analysis for detection of residual disease and recurrence in surgically treated HNSCC patients.
Journal: NPJ precision oncology
Published: November 19, 2025
Shared genetic architecture of psychoactive substance use and pan-cancer: insights from a large‑scale genome‑wide cross‑trait analysis.
Journal: BMC medicine
Published: September 01, 2025
EpCAM supports exit from pluripotency of embryonic stem cells via Eomes.
Journal: Cell death & disease
Published: August 08, 2025
Spatial transcriptomics reveals a molecular tumor budding signature in head and neck cancer.
Journal: Genome medicine
Published: August 08, 2025
EGFR-mediated local invasiveness and response to Cetuximab in head and neck cancer.
Journal: Molecular cancer
Published: October 09, 2024
Multi-omics analysis to uncover the molecular basis of tumor budding in head and neck squamous cell carcinoma.
Journal: NPJ precision oncology
Published: August 15, 2024
The Nuclear Speckles Protein SRRM2 Is Exposed on the Surface of Cancer Cells.
Journal: Cells
Published: June 14, 2024
TSPAN8+ myofibroblastic cancer-associated fibroblasts promote chemoresistance in patients with breast cancer.
Journal: Science translational medicine
Published: April 03, 2024
Proteomic Profiling of Serum Extracellular Vesicles Identifies Diagnostic Signatures and Therapeutic Targets in Breast Cancer.
Journal: Cancer research
Published: December 16, 2023
Metabolic pathway-based subtypes associate glycan biosynthesis and treatment response in head and neck cancer.
Journal: NPJ precision oncology
Published: August 10, 2023
Last Updated: 09/26/2026